Piper Sandler Maintains Overweight on IBEX, Lowers Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Arvind Ramnani has maintained an Overweight rating on IBEX (NASDAQ:IBEX) but lowered the price target from $24 to $17.

September 18, 2023 | 8:08 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Piper Sandler has maintained an Overweight rating on IBEX but lowered the price target from $24 to $17.
The news is directly about IBEX and is likely to impact its stock price. While the Overweight rating suggests that the analyst believes the stock will outperform its industry in the future, the lowering of the price target may create a negative sentiment among investors, potentially putting downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100